SCHEDULE 13G/A
Item 1.
Bioventus Inc.
|
(b) |
Address of Issuers Principal Executive Offices: |
4721 Emperor Boulevard, Suite 100, Durham, North Carolina 27703
Item 2.
|
(a) |
Name of Person Filing: |
This Amendment No. 1 to Schedule 13G amends the Schedule 13G filed on January 31, 2022 and is being filed jointly by EW Healthcare
Partners Acquisition Fund, L.P., a Delaware limited partnership (EWHP), White Pine Medical LLC, a Delaware limited liability company (WPM), EW Healthcare Partners Acquisition Fund GP, L.P., a
Delaware limited partnership, the general partner of EWHP (the EWHP GP), EW Healthcare Partners Acquisition Fund UGP, LLC, a Delaware limited liability company, the general partner of EWHP GP (the General
Partner), Martin P. Sutter, an individual, Petri Vainio, an individual, Ron Eastman, an individual, and R. Scott Barry, an individual, (each a Manager, collectively, the Managers, and
together with EWHP, WPM, EWHP GP and the General Partner, the Reporting Persons).
|
(b) |
Address of Principal Business Office: |
The address of the principal business of each of the Reporting Persons is 21 Waterway, Suite 225, The Woodlands, Texas 77380.
(i) EWHP and EWHP GP are each Delaware limited partnerships; (ii) WPM and the General Partner are each a Delaware limited liability
company; and (iii) each Manager is an individual who is a citizen of the United States.
|
(d) |
Title and Class of Securities: |
Class A Common Stock, par value $.001 per share (Class A Common Stock).
09075A108
Item 3. If this statement
is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable.
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in
Item 1.
(a) |
Amount Beneficially Owned: |
For EWHP, 12,096,702 shares.
For WPM, 924,622 shares.
For
each of EWHP GP and the General Partner, 13,021,324 shares.
For each of the Managers: 13,021,324 shares.